The difference in animal obesity detected in the two studies could be due to different time regimes of drug treatment (8 weeks vs. 2 weeks), differences in strains of mice used (see below for comments on C57Bl/6 strain), or specificity of different A2AR agonists used. This evidence concerns the gene ADORA2A and obesity due to melanocortin 4 receptor deficiency.